Deunoxavir Marboxil

玛氘诺沙韦

Report date: 2025/03/17 13:31:45
NME

Base Information

Drug NameDeunoxavir Marboxil
Drug Alias NameADC-189
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionPolymerase acidic protein inhibitorsVirus replication inhibitorsEndonucleases inhibitors
TargetsPolymerase acidic proteinEndonucleases
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesJiaxing AnDiCon Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSimcere Pharmaceutical Group LtdJiaxing AnDiCon Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A